Literature DB >> 9653007

Reversible dysgeusia attributed to losartan.

M Heeringa, E P van Puijenbroek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9653007     DOI： 10.7326/0003-4819-129-1-199807010-00023

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Drug points: Dysgeusia and burning mouth syndrome by eprosartan.

Authors:  Xavier Castells; Isidre Rodoreda; Consuelo Pedrós; Gloria Cereza; Joan-Ramon Laporte
Journal:  BMJ       Date:  2002-11-30

2.  Angiotensin II receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan.

Authors:  Shuichi Tsuruoka; Michi Wakaumi; Takashi Ioka; Hisashi Yamamoto; Hitoshi Ando; Kohichi Sugimoto; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

Review 3.  Comparative safety and tolerability of angiotensin II receptor antagonists.

Authors:  L Mazzolai; M Burnier
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

Review 4.  Clinical pharmacokinetics of losartan.

Authors:  Domenic A Sica; Todd W B Gehr; Siddhartha Ghosh
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects.

Authors:  Shuichi Tsuruoka; Michi Wakaumi; Kenta Nishiki; Nobutaka Araki; Kenichi Harada; Koichi Sugimoto; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

Review 6.  Drug-induced taste disorders.

Authors:  Richard L Doty; Muhammad Shah; Steven M Bromley
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 7.  Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review.

Authors:  Xiaoru Che; Yuandong Li; Yuanjian Fang; Cesar Reis; Huan Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.